[1]
“TWELVE-MONTH CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION TREATED WITH SACUBITRIL/VALSARTAN AT THE UNIVERSITY MEDICAL CENTER, HO CHI MINH CITY”, YHCĐ, vol. 67, no. 7, July 2026, doi: 10.52163/yhc.v67i7.5885.